Perceptive Advisors Portfolio holdings
Perceptive Advisors is a life sciences investment firm whose flagship Perceptive Life Sciences Fund puts most of its money into publicly traded small and mid-sized companies. Joseph Edelman, a former senior analyst at Paramount Capital's Aries Fund, a biotechnology hedge fund, founded the firm in 1999. It launched its first credit fund in 2013, and in 2019 teamed up with the biotech startup accelerator Xontogeny to launch its first venture capital fund.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KDMN
Kadmon Holdings
KDMN
|
+$20.1M |
| 2 |
AVDL
Avadel Pharmaceuticals
AVDL
|
+$17.8M |
| 3 |
Radius Health
RDUS
|
+$15.9M |
| 4 |
ARAV
Aravive
ARAV
|
+$14.4M |
| 5 |
Eagle Pharmaceuticals
EGRX
|
+$13.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MDVN
Medivation
MDVN
|
+$45.8M |
| 2 |
TSRO
Tesaro
TSRO
|
+$43.1M |
| 3 |
Nevro
NVRO
|
+$31.9M |
| 4 |
CPXX
Celator Pharmaceuticals
CPXX
|
+$25.3M |
| 5 |
STJ
St. Jude Medical
STJ
|
+$18.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 96.62% |
| 2 | Miscellaneous | 2.58% |
| 3 | Consumer Staples | 0.5% |
| 4 | Technology | 0.1% |
| 5 | Consumer Discretionary | 0.07% |
Similar funds
Perceptive Advisors's Q3 2016 Portfolio in Review
As of Q3 2016, Perceptive Advisors held 236 positions worth $1.55B, up 7.4% from $1.44B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Perceptive Advisors withdrew a net $72.8M in Q3 2016, closing 43 positions and reducing 57 holdings. Its most notable exit was Medivation, an estimated $45.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 79% a quarter earlier, followed by Miscellaneous and Consumer Staples.
Against the trend, Perceptive Advisors opened a new position in Kadmon Holdings worth $16.2M.
- Perceptive Advisors's largest Q3 2016 buy was Kadmon Holdings: 2,209,657 shares worth $16.2M.
- Perceptive Advisors added most to Aravive in Q3 2016, an estimated $14.4M increase.
- Perceptive Advisors's biggest Q3 2016 reduction was Tesaro, cutting an estimated $43.1M.
- Perceptive Advisors fully exited Medivation in Q3 2016, selling an estimated $45.8M.
- Perceptive Advisors's ten largest holdings make up 50% of its $1.55B portfolio in Q3 2016.
- Perceptive Advisors opened 61 new positions and closed 43 in Q3 2016.
- Perceptive Advisors's portfolio value rose 7.4% quarter-over-quarter to $1.55B.
Based on Perceptive Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.